Status:
UNKNOWN
Analysis of Cardiac Biomarkers, ECG and CPET Results in Children With Cardiomyopathies
Lead Sponsor:
Katarzyna Łuczak-Woźniak
Conditions:
Cardiomyopathies
Eligibility:
All Genders
1-18 years
Brief Summary
The aim of the study is to analyze cardiac biomarkers, electrocardiograms and cardio-pulmonary exercise test (CPET) results in children with cardiomyopathies.
Detailed Description
The study group will consist of children that have been diagnosed with DCM, HCM or LVNC. The control group will be composed of healthy children. Examination of cardiac biomarkers (in the study group),...
Eligibility Criteria
Inclusion
- Children with HCM, DCM, LVNC diagnosed in 2D echo.
- Healthy children with no congenital heart disease (CHD) in 2D echo.
- Patients who signed consent form.
Exclusion
- Patients with coexisting CHD, kidney and liver disfunction, taking anti-psychotic and anti-depressant medication, or patients with bundle bunch blocks in ECG.
- no consent form signed.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04316923
Start Date
March 1 2020
End Date
March 1 2024
Last Update
August 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Univeristy of Warsaw
Warsaw, Poland